RBL LLC welcomes Devyn Smith to board of directors

HOUSTON, April 22, 2025 /PRNewswire/ -- RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, announced the appointment of Devyn Smith to its board of directors. Smith, a distinguished biopharmaceutical executive and current CEO of Arbor Biotechnologies, brings extensive experience in regenerative medicine, company formation and commercial strategy that will be instrumental in RBL's mission to accelerate lifesaving therapies from bench to bedside.

Previous
Previous

RBL LLC Announces Launch of SteerBio with an up to $18.2 Million Federal Award to Pioneer a Curative Therapy for Lymphedema

Next
Next

Rice Biotech Launch Pad and RBL LLC to celebrate official launch and lab opening